Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

Published:2024-04 Issue:10434 Volume:403 Page:e21-e31
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Shi Qingyang,Wang Yang,Hao Qiukui,Vandvik Per Olav,Guyatt Gordon,Li Jing,Chen Zhe,Xu Shishi,Shen Yanjiao,Ge Long,Sun Feng,Li Ling,Yu Jiajie,Nong Kailei,Zou Xinyu,Zhu Siyi,Wang Cong,Zhang Shengzhao,Qiao Zhi,Jian Zhongyu,Li Ya,Zhang Xinyi,Chen Kerun,Qu Furong,Wu Yuan,He Yazhou,Tian Haoming,Li Sheyu

Funder

West China Hospital, Sichuan University

Publisher

Elsevier BV

Reference43 articles.

1. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants;Lancet,2016

2. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity;Garvey;Endocr Pract,2016

3. Management of obesity;Bray;Lancet,2016

4. Obesity in adults: a clinical practice guideline;Wharton;CMAJ,2020

5. Weight loss intervention adherence and factors promoting adherence: a meta-analysis;Lemstra;Patient Prefer Adherence,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

2. Medications for Obesity;JAMA;2024-08-20

3. Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders;Obesity Science & Practice;2024-08

4. Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy;JAMA Ophthalmology;2024-08-01

5. Western diets and chronic diseases;Nature Medicine;2024-07-31